高血压是一种以慢性血压增高为特征的疾病，必须通过药物治疗、改变生活方式或两者联合来监测、治疗和控制高血压。
Hypertension is a disorder characterized by chronically high blood pressure. It must be monitored, treated and controlled by medication, lifestyle changes, or a combination of both.
高血压预防、监测、评估及治疗联合委员会(JNC)于1997年降低糖尿病人群的血压目标值，2003年该委员会再次降低糖尿病人群的血压目标值。
In 1997, and again in 2003, the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High blood pressure (JNC) lowered blood pressure goals for people with diabetes.
对此类患者应以简化治疗作为初始疗法，但简化并非单药，而是在必要时采用几种抗高血压药物的简单联合。
In those patients we probably should start them on single therapy but not necessarily with a single drug but single therapy of several classes of antihypertensive drugs when they are needed.
结论综合考虑，厄贝沙坦片与氢氯噻嗪片联合应用是治疗单纯性收缩期高血压的最佳方案。
CONCLUSION Taking everything into consideration, Irbesartan combined with Hydrochlorothiazide was the best scheme in the treatment of the pure systolic hypertension.
目的比较厄贝沙坦与硝苯地平缓释片或氢氯噻嗪片联合治疗单纯性收缩期高血压的经济效果。
OBJECTIVE to compare the cost-effectiveness between Irbesartan combined with Extended Release Nifedipine or Hydrochlorothiazide in the treatment of the Pure Systolic Hypertension.
本研究观察氨氯地平、卡托普利联合治疗2型糖尿病高血压的有效性及安全性。
This research observation ammonia chlorine horizontal, Catto Pulley treats 2 diabetes hypertension's validity and the security jointly.
《国际循环》：联合治疗通常是原发性高血压合并糖尿病患者的一种有效治疗方法。在这些患者中是否有优选的治疗策略？
International Circulation: Usually, combination therapy is an effective treatment used in essential hypertensive patients with diabetes. Is there optimized treatment strategy in these patients?
目的分析小剂量、联合、个体化药物治疗原发性高血压(EH)的临床效果。
Aim To analyses the therapeutic effect of essential hypertension (EH) with drugs treatment of low dose, combination and individual.
摘要：目的：观察硝苯地平联合氢氯噻嗪治疗老年高血压的疗效和安全性。
ABSTRACT: OBJECTIVE: To observe the efficacy and safety of nifedipine combined with hydrochlorothiazide in the treatment of elderly patients with hypertension.
目的观察苯那普利联合小剂量氢氯噻嗪治疗原发性轻中度高血压的疗效。
Objective To observe the effect of Benazapril in combination with low dose of Hydrochlorothiazide on essential hypertension.
目的观察尿毒清颗粒联合洛汀新治疗肾性高血压的疗效和安全性。
Objective To observe the therapeutic effect and safety of niaoduqing particles combined with lotensin on renal hypertension (RH).
结论：缬沙坦、卡托普利缓释片是治疗高血压的有效药物，二者联合应用是治疗尿毒症顽固性高血压的较好方法。
Conclusion: Both captopril sustained-release tablets and valsartan are effective, and the combining use of the two drugs is effective on refractory hypertension in uremia patients.
目的探讨曲美他嗪联合厄贝沙坦治疗高血压病伴阵发性房颤的疗效及对左房内径、C反应蛋白(crp)的影响。
Objective To investigate the effect of trimetazidine combined with irbesartan on left atrial diameter and C-reactive protein (CRP) in hypertension patients with paroxysmal atrial fibrillation (PAF).
结论药物治疗原发性高血压时，应首选缬沙坦联合硝苯地平控释片治疗的方案，可提高临床疗效。
Conclusion When we treat primary hypertension patients, we should use the Valsartan and Nifedipine, it could improve the clinical effects.
目的观察氯沙坦与波依定联合用药治疗慢性肾衰竭并高血压的效果。
ObjectiveTo observe the effects of combination of losartan and plendil for patients with chronic renal failure complicated hypertension.
目的探讨伲福达和倍他乐克联合小剂量应用治疗原发性高血压病人的效果。
Objective To assess the efficacy of low-dose Nifuda and Betaloc combination for essential hypertension.
目的：观察欣然联合天麻钩藤饮治疗重度高血压的疗效。
Objective: To observe the therapeutic effect on grave hypertension treated by Xin Ran combined with Gastrodia Rhizome and Rhynchophylla Decoction.
我个人认为，两种药物联合的SPC用做2级和3级高血压的初始治疗很可能是向正确的方向迈出了一步。
I personally think initial therapy of stage 2 and 3 hypertension with dual compound SPC is probably a step in the right direction.
2007年欧洲高血压防治指南推荐的优选降压方案之一是联合acei治疗。
The 2007 Guideline of European Hypertension Prevents and Controls recommends that one of the optimal plan of blood lowering is uniting the ACEI treatment.
事实上，ADVANCE研究使用了利尿剂和ACEI的联合，结果显示治疗糖尿病患者的高血压时死亡率显著下降。
The ADVANCE study actually used a diuretic and an ace inhibitor combination and showed a significant mortality benefit in treating hypertension in diabetics.
第三，近几年抗高血压药物治疗的大动作是转向联合治疗，尤其是在单一制剂中。
Thirdly, the big move in antihypertensive drug therapy in recent years has been towards combination therapy, particularly in a single preparation.
其次是抗高血压药物的联合治疗。 在本次年会上，将有很多观察联合治疗的试验揭晓，比如TALENT试验，比较了哪种药物治疗更好。
The second is related to combined therapy strategies and the presentation of clinical trials, like the TALENT trial, comparing which drug treatment strategy is better.
目的探讨厄贝沙坦联合胺碘酮治疗高血压病伴心房颤动的临床效果。
Objective To discuss the clinical curative effect of Irbesartan combined with Amiodarone in treating hypertension complicated with paroxysmal atrial fibrillation.
目的：观察对伴有心血管危险因素的高血压患者进行联合降压治疗对血压达标率的影响。
Object: to observe the influence of the associated antihypertensive therapy on the rate of reach mark blood pressure in patients with essential hypertension who had cardiovascular risk factors.
因此，将这两种最常用的高血压治疗药物联合在单个片剂中用于很多需要不止一种药物的患者看起来是种很自然的做法。
So it seems natural to combine two of the most popular medications we use for blood pressure in a single pill for the many people who require more than one.
结果：氨氯地平联合依那普利治疗高血压病左心室舒张功能不全的临床有效率为90.5%。
RESULTS:The clinical effective rate of amlodipine and enalapril for hypertension left ventricular diastolic dysfunction was 90.5%.
结论厄贝沙坦联合氢氯噻嗪疗效好，是治疗重度高血压安全有效的方法之一。
Conclusion The combination of Irbesartan plus DihydroChlorothiazide has definite benefit in patients with severe hyperpiesia.
结论厄贝沙坦联合氢氯噻嗪疗效好，是治疗重度高血压安全有效的方法之一。
Conclusion The combination of Irbesartan plus DihydroChlorothiazide has definite benefit in patients with severe hyperpiesia.
应用推荐